Neurocrine Shares Hit Highs on Sales Spike, Strong Pipeline

Biopharmaceutical firm Neurocrine Biosciences, Inc. (NBIX) up over 35% in a year and 17% since outlier inflows in May.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.